section name header

Pronunciation ⬇

butenafine: byoo-TEN-a-feen

ciclopirox: sye-kloe-PEER-ox

clotrimazole: kloe-TRYE-ma-zole

econazole: ee-KON-a-zole

efinaconazole: eff-in-a-KON-a-zole

ketoconazole: kee-toe-KOE-na-zole

luliconazole: loo-li-KON-a-zole

miconazole: mye-KON-a-zole

naftifine: NAFF-ti-feen

nystatin: nye-STAT-in

oxiconazole: ox-i-KON-a-zole

sertaconazole: ser-ta-KON-a-zole

sulconazole: sul-KON-a-zole

tavaborole: ta-va-BOR-ole

terbinafine: ter-BIN-a-feen

tolnaftate: tol-NAFF-tate

Classifications ⬆ ⬇

Therapeutic Classification: antifungals (topical)

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Butenafine, nystatin, clotrimazole, econazole, efinaconazole, ketoconazole, luliconazole, miconazole, naftifine, oxiconazole, sertaconazole, sulconazole, and terbinafine affect the synthesis of the fungal cell wall, allowing leakage of cellular contents. Tolnaftate distorts the hyphae and stunts mycelial growth in fungi. Ciclopirox inhibits the transport of essential elements in the fungal cell, disrupting the synthesis of DNA, RNA, and protein. Tavaborole inhibits fungal protein synthesis via inhibition of aminoacyl-transfer ribonucleic acid (tRNA) synthetase.
Therapeutic effects:
  • Decrease in symptoms of fungal infection.

Pharmacokinetics ⬆ ⬇

Absorption: Absorption through intact skin is minimal.

Distribution: Distribution after topical administration is primarily local.

Metabolism/Excretion: Metabolism and excretion not known following local application.

Half-Life: Butenafine: 35 hr; Ciclopirox: 5.5 hr (gel); Efinaconazole: 29.9 hr; Terbinafine: 21 hr.

Time/Action Profile ⬆ ⬇

( resolution of symptoms/lesions‡)
ROUTEONSETPEAKDURATION
Butenafineunknownup to 4 wkunknown
Luliconazoleunknown3–4 wkunknown
Tolnaftate24–72 hrunknownunknown

‡Only the drugs with known information included in this table.



Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Local: burning, itching, local hypersensitivity reactions, redness, stinging

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Butenafine

Ciclopirox

Clotrimazole

Econazole

Efinaconazole

Ketoconazole

Luliconazole

Miconazole

Naftifine

Nystatin

Oxiconazole

Sertaconazole

Sulconazole

Tavaborole

Terbinafine

Tolnaftate

Availability ⬆ ⬇

Butenafine

(Generic available)

Ciclopirox

(Generic available)

Clotrimazole

(Generic available)

Econazole

(Generic available)

Efinaconazole

(Generic available)

Ketoconazole

(Generic available)

Luliconazole

(Generic available)

Miconazole

(Generic available)

Naftifine

Nystatin

(Generic available)

Oxiconazole

(Generic available)

Sertaconazole

Sulconazole

(Generic available)

Tavaborole

(Generic available)

Terbinafine

(Generic available)

Tolnaftate

(Generic available)

Assessment ⬆ ⬇

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

butenafine: Lotrimin Ultra,

ciclopirox: Ciclodan,

clotrimazole: Alevazol,

econazole: Ecoza,

efinaconazole: Jublia,

ketoconazole: Ketodan,

luliconazole: Luzu,

miconazole: Fungoid, Lotrimin AF, Micatin, Zeasorb-AF,

naftifine: Naftin,

nystatin: Klayesta, Mycostatin, Nyamyc, Nystop,

oxiconazole: Oxistat,

sertaconazole: Ertaczo,

sulconazole: Exelderm,

tavaborole: Kerydin,

terbinafine: Lamisil AT,

tolnaftate: Tinactin

Canadian Brand Names ⬆

ciclopirox: Loprox,

clotrimazole: Canesten, Clotrimaderm,

ketoconazole: Ketoderm,

miconazole: Micozole,

nystatin: Nyaderm,

terbinafine: Lamisil